Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The recent surge in takeovers of British listed companies, with around £100b of deals in 2026, has sharpened investor focus on homegrown growth stories before buyers swoop. Healthy, fast expanding UK businesses that also keep their finances in check look especially interesting. This article highlights three stocks from a high growth potential screener that filters for earnings expansion and balance sheet strength to help you find candidates that may warrant deeper research. The three stocks...
With Bund yields at 15 year highs as Europe wrestles with persistent inflation, investors are being pushed to rethink where growth can realistically come from next. Higher borrowing costs can strain weaker companies, yet they also highlight the appeal of businesses that analysts expect to grow earnings and maintain solid balance sheets. This article spotlights three stocks from the Healthy high growth potential screener that fit that brief. The stocks profiled below are just a starting...
With 10 year US Treasury yields near 4.7% after hawkish comments from Fed Chair Warsh on persistent inflation, growth stocks face a tougher hurdle. In that environment, earnings power and financial strength take on increased importance. This Healthy High Growth Potential screener focuses on companies analysts expect to deliver strong earnings growth while keeping balance sheets in check. This article highlights three stocks from the screener that merit closer attention. The stocks highlighted...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.